- Home
- VTVT vs NEUE Comparison
VTVT vs NEUE Comparison
Compare VTVT & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- NEUE
- Stock Information
- Founded
- VTVT 2015
- NEUE 2015
- Country
- VTVT United States
- NEUE United States
- Employees
- VTVT N/A
- NEUE N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- NEUE
- Sector
- VTVT Health Care
- NEUE
- Exchange
- VTVT Nasdaq
- NEUE NYSE
- Market Cap
- VTVT 56.7M
- NEUE 57.1M
- IPO Year
- VTVT 2015
- NEUE 2021
- Fundamental
- Price
- VTVT $21.94
- NEUE $6.89
- Analyst Decision
- VTVT Strong Buy
- NEUE Hold
- Analyst Count
- VTVT 2
- NEUE 1
- Target Price
- VTVT $35.50
- NEUE $7.00
- AVG Volume (30 Days)
- VTVT 9.3K
- NEUE 9.9K
- Earning Date
- VTVT 05-27-2025
- NEUE 05-08-2025
- Dividend Yield
- VTVT N/A
- NEUE N/A
- EPS Growth
- VTVT N/A
- NEUE N/A
- EPS
- VTVT N/A
- NEUE N/A
- Revenue
- VTVT $1,017,000.00
- NEUE $907,349,000.00
- Revenue This Year
- VTVT N/A
- NEUE $33.99
- Revenue Next Year
- VTVT N/A
- NEUE $5.90
- P/E Ratio
- VTVT N/A
- NEUE N/A
- Revenue Growth
- VTVT N/A
- NEUE N/A
- 52 Week Low
- VTVT $12.12
- NEUE $3.79
- 52 Week High
- VTVT $29.01
- NEUE $7.66
- Technical
- Relative Strength Index (RSI)
- VTVT 57.22
- NEUE 54.49
- Support Level
- VTVT $20.12
- NEUE $6.55
- Resistance Level
- VTVT $21.52
- NEUE $6.93
- Average True Range (ATR)
- VTVT 1.23
- NEUE 0.19
- MACD
- VTVT -0.09
- NEUE 0.00
- Stochastic Oscillator
- VTVT 67.00
- NEUE 71.05
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.